FRI149 Internal Medicine Residents Knowledge On Testing For Treatment Resistant Hypertension With The Focus On Primary Aldosteronism - Interim Analysis

Disclosure: N. Markovic: None. M. Brankovic: None. A. Palani: None. D. Matassa: None. Studies have shown that primary aldosteronism (PA) is an underlying cause in up to 23% of patients diagnosed with treatment-resistant hypertension (TRH).(1) However, recent data have suggested that less than 2% of...

Descripción completa

Detalles Bibliográficos
Autores principales: Markovic, Nikolina, Brankovic, Milos, Palani, Arthi, Matassa, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Cardiovascular Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554843/
http://dx.doi.org/10.1210/jendso/bvad114.661

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554843/
http://dx.doi.org/10.1210/jendso/bvad114.661

Ejemplares similares